235 related articles for article (PubMed ID: 14648657)
1. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.
Van Trappen PO; Steele D; Lowe DG; Baithun S; Beasley N; Thiele W; Weich H; Krishnan J; Shepherd JH; Pepper MS; Jackson DG; Sleeman JP; Jacobs IJ
J Pathol; 2003 Dec; 201(4):544-54. PubMed ID: 14648657
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
Yuanming L; Feng G; Lei T; Ying W
Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
[TBL] [Abstract][Full Text] [Related]
3. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
5. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
Hammes LS; Tekmal RR; Naud P; Edelweiss MI; Kirma N; Valente PT; Syrjänen KJ; Cunha-Filho JS
Gynecol Oncol; 2008 Sep; 110(3):445-51. PubMed ID: 18565574
[TBL] [Abstract][Full Text] [Related]
7. Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.
Cimpean AM; Mazuru V; Saptefrati L; Ceausu R; Raica M
Histol Histopathol; 2012 Dec; 27(12):1543-50. PubMed ID: 23059885
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
11. Expression of VEGF, VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix.
Jach R; Dulinska-Litewka J; Laidler P; Szczudrawa A; Kopera A; Szczudlik L; Pawlik M; Zajac K; Mak M; Basta A
Front Biosci (Elite Ed); 2010 Jan; 2(2):411-23. PubMed ID: 20036889
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
Parr C; Jiang WG
Int J Oncol; 2003 Aug; 23(2):533-9. PubMed ID: 12851706
[TBL] [Abstract][Full Text] [Related]
14. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
15. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.
Yu H; Zhang S; Zhang R; Zhang L
J Exp Clin Cancer Res; 2009 Jul; 28(1):98. PubMed ID: 19589137
[TBL] [Abstract][Full Text] [Related]
16. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
[TBL] [Abstract][Full Text] [Related]
18. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
Blacker HA; Orgeig S
J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Weis B; Ben-Baruch G; Reich R
Gynecol Oncol; 1999 Mar; 72(3):380-6. PubMed ID: 10053110
[TBL] [Abstract][Full Text] [Related]
20. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.
Soufla G; Sifakis S; Baritaki S; Zafiropoulos A; Koumantakis E; Spandidos DA
Cancer Lett; 2005 Apr; 221(1):105-18. PubMed ID: 15797633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
